Ciladopa hydrochloride

INCB086550 (PD-1/PD-L1-IN-8: example 24) is a PD-1/PD-L1 inhibitor, with an IC 50 &lt:= 10 nM.Form:Solid.

INCB086550 (PD-1/PD-L1-IN-8: example 24) is a PD-1/PD-L1 inhibitor, with an IC 50 &lt:= 10 nM.Form:Solid.

INCB086550 (PD-1/PD-L1-IN-8: example 24) is a PD-1/PD-L1 inhibitor, with an IC 50 &lt:= 10 nM.

Indeno(1,2,3-cd)pyrene solution.

A PDE4 inhibitor and muscarinic acetylcholine receptor binder.

A PDE4 inhibitor and muscarinic acetylcholine receptor binder.

A PDE4 inhibitor and muscarinic acetylcholine receptor binder.

ITI-214 is a potent, CNS-active, orally bioavailable PDE1 inhibitor ( K i of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 inhibits recombinant

ITI-214 is a potent, CNS-active, orally bioavailable PDE1 inhibitor ( K i of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 inhibits recombinant

ITI-214 is a potent, CNS-active, orally bioavailable PDE1 inhibitor ( K i of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 inhibits recombinant

ITI-214 is a potent, CNS-active, orally bioavailable PDE1 inhibitor ( K i of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 inhibits recombinant

L-CITRULLINE MONOHYDROCHLORIDE